Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone (Q44183076)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 October 2002
edit
Language Label Description Also known as
English
Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone
scientific article published on 15 October 2002

    Statements

    Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit